Nasrat Hakim is New President and Chief Executive Officer of ELTP; Doug Plassche Named Executive Vice President of Operations

Nasrat Hakim and Doug Plassche are now heading up Elite Pharmaceuticals in an effort to bring a grip of drugs to the marketplace. A series of events beginning with last week's acquisition of 12 (+1 anda) patented drugs from Mikah. Volume up, selling down. The rumor mill is sweltering and has a good vibe, and importantly, ELTP's move to bring these guys in to fill big shoes appears a subtle stroke of genius at the moment. Lets not forget that earnings are due out this week, so all hopes are for this reporting to really take things up a notch. Historically, during the last 3 years, earnings have been one let down after the next, until last quarter when signs of life finally arrived. Cautious investors are careful not to fall victim, wisely, to some makeshift crew. But ELTP is trying to side-rail these notions and become a legit threat to market share. Things are getting interesting, but the outcome is far from predictable. Stay tuned...